Athanase Innovation AB (OSTO:ATIN) Research & Development: kr0.00 Mil (TTM As of Dec. 2020)


OSTO:ATIN Athanase Innovation AB OSTO:ATIN
26 GF Score
Price kr17.80
View Full Analysis

What is Athanase Innovation AB Research & Development?

Athanase Innovation AB OSTO:ATIN 26 Research & Development is kr0.00 Mil as of Dec. 2020. GuruFocus rates OSTO:ATIN with a GF Score™ of 26/100.

Research & Development is the aggregate amount of research and development expenses during the year. Athanase Innovation AB's Research & Development for the six months ended in Dec. 2020 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 was kr0.00 Mil.

Athanase Innovation AB  (OSTO:ATIN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Athanase Innovation AB Research & Development Related Terms

Athanase Innovation AB Research & Development Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB Research & Development Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Research & Development
0.00 0.00 0.00

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
OSTO:ATIN
26GF Score
Athanase Innovation AB OSTO:ATIN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.00 Mil mean?
Athanase Innovation AB (OSTO:ATIN) has a Research & Development of kr0.00 Mil as of Dec. 2020. Research and development expense is the total cost for research and development activities. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's Research & Development too high?
Athanase Innovation AB's current Research & Development is kr0.00 Mil. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's Research & Development compare to EVG and SMM?
Athanase Innovation AB's Research & Development of kr0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Athanase Innovation AB and its competitors. Athanase Innovation AB's current Research & Development is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current Research & Development of kr0.00 Mil. The current Research & Development is kr0.00 Mil. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current Research & Development is kr0.00 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for OSTO:ATIN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.80
Price